Hos patienter med kompenseret leversygdom er disse stigninger i serum- ALAT generelt hverken ledsaget af en stigning i serum- bilirubinkoncentrationen eller af hepatisk dekompensation.
In patients with compensated liver disease, these increases in serum ALT are generally not accompanied by an increase in serum bilirubin concentrations or hepatic decompensation.